Abstract
We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangiogenic treatment.
Original language | English |
---|---|
Pages (from-to) | 1787-1788 |
Number of pages | 2 |
Journal | Lancet |
Volume | 355 |
Issue number | 9217 |
Publication status | Published - May 20 2000 |
ASJC Scopus subject areas
- Medicine(all)